About Sir Run Run Hospital Nanjing Medical University
Clinical Trials at Sir Run Run Hospital Nanjing Medical University
During the past decade, Sir Run Run Hospital Nanjing Medical University conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Sir Run Run Hospital Nanjing Medical University" #1 sponsor was "Guangdong Raynovent Biotech Co., Ltd" with 2 trials, followed by "Biohaven Pharmaceuticals, Inc." with 1 trials
sponsored, "CSPC ZhongQi Pharmaceutical Technology Co., Ltd." with 1 trials sponsored, "China Academy of Chinese Medical Sciences" with 1 trials sponsored and "Chipscreen Biosciences, Ltd."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Sir Run Run Hospital Nanjing Medical University"
#1 collaborator was "BioShin Limited" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Sir Run Run Hospital Nanjing Medical University
According to Clinical.Site data, the most researched conditions in "Sir Run Run Hospital Nanjing Medical University" are
"Influenza A" (2 trials), "Acute Migraine" (1 trials), "Bronchial Asthma" (1 trials), "Helicobacter Pylori Infection" (1 trials) and "SARS-CoV-2" (1 trials). Many other conditions were trialed in "Sir Run Run Hospital Nanjing Medical University" in a lesser frequency.
Clinical Trials Intervention Types at Sir Run Run Hospital Nanjing Medical University
Most popular intervention types in "Sir Run Run Hospital Nanjing Medical University" are "Drug" (6 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "20 μg dose of SYS6006" (1 trials), "30 μg dose of SYS6006" (1 trials), "Amoxicillin" (1 trials) and "Chiglitazar 32mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sir Run Run Hospital Nanjing Medical University
The vast majority of trials in "Sir Run Run Hospital Nanjing Medical University" are
7 trials for "All" genders.
Clinical Trials Status at Sir Run Run Hospital Nanjing Medical University
Currently, there are NaN active trials in "Sir Run Run Hospital Nanjing Medical University".
1 are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Sir Run Run Hospital Nanjing Medical University,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sir Run Run Hospital Nanjing Medical University, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".